Department of Conservation and Recreation

whitePaper | October 5, 2022

Cloud is helping to modernize government services and transform citizen interactions. But cloud security hasn’t kept up with the pace of cloud adoption. Ensuring a secure, compliant environment in the cloud is critical— particularly for public-sector organizations that collect, store and manage highly sensitive data on behalf of their citizens.

whitePaper | November 26, 2019

The adoption of Internet of Things (IoT) technologies by public sector entities can result in many benefits: increased public safety with video surveillance or street lights, traffic management systems to control vehicle flow, and enhanced medical experience with connected infusion pumps and monitoring systems that communicate with patient records systems. Providing these and other new capabilities, all while increasing employee productivity, is one of the key reasons we are seeing an explosion of IoT deployment in the public sector.

whitePaper | October 5, 2022

Insights into how Atlassian's Jira and Confluence can support government agencies to work more collaboratively and deliver more results and services - effectively - to stakeholders and communities.

whitePaper | March 30, 2022

Why have we written disparaging statements about government when our firm is so deeply committed to public sector excellence? These include statements like “as the fire rages on, our governments seem powerless” and “hunches no longer pass for evidence these days, unless we’re talking about government policy.” We have compared the policy-making process to a chaotic game of tag and suggested that government policymakers can act as seemingly irrational as Cosmo Kramer did on Seinfeld.

whitePaper | December 2, 2019

The Autumn 2018 Budget commits HM Government to review how it can use Artificial Intelligence (AI), automation and data in new ways to drive public sector productivity and wider economic benefits.

whitePaper | February 12, 2020

Both the U.S. Government and biopharmaceutical industry have been central engines for developing new medical treatments and cures, thereby lowering the effective price of better health for patients worldwide. The sector has done so by being both the world leader in these biopharmaceutical cures and treatments as well as the source of the returns that are required to fund new medical R&D investments.